These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35870081)

  • 21. The Use of Thrombolytic Therapy in the Treatment of Frostbite Injury.
    Wexler A; Zavala S
    J Burn Care Res; 2017; 38(5):e877-e881. PubMed ID: 28296671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. American Burn Association Clinical Practice Guidelines on the Treatment of Severe Frostbite.
    Wibbenmeyer L; Lacey AM; Endorf FW; Logsetty S; Wagner ALL; Gibson ALF; Nygaard RM
    J Burn Care Res; 2024 May; 45(3):541-556. PubMed ID: 37045447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iloprost (Aurlumyn) for frostbite.
    Med Lett Drugs Ther; 2024 Jul; 66(1707):114. PubMed ID: 39008104
    [No Abstract]   [Full Text] [Related]  

  • 24. What Interventional Radiologists Need to Know About Managing Severe Frostbite: A Meta-Analysis of Thrombolytic Therapy.
    Lee J; Higgins MCSS
    AJR Am J Roentgenol; 2020 Apr; 214(4):930-937. PubMed ID: 32023122
    [No Abstract]   [Full Text] [Related]  

  • 25. Can iloprost be used for treatment of cold weather injury at the point of wounding in a forward operating environment? A literature review.
    Lowe J; Warner M
    Int J Circumpolar Health; 2023 Dec; 82(1):2210340. PubMed ID: 37154780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of the Efficacy of Iloprost Treatment in Amputations Due to Burn.
    Sevil FC; Sevil H; Tort M; Öztürk M
    J Burn Care Res; 2021 Feb; 42(1):82-86. PubMed ID: 32735678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An open-label study to evaluate the safety and efficacy of tissue plasminogen activator in treatment of severe frostbite.
    Twomey JA; Peltier GL; Zera RT
    J Trauma; 2005 Dec; 59(6):1350-4; discussion 1354-5. PubMed ID: 16394908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of a novel method of intravenous infusion of the prostaglandin analogue iloprost for the treatment of lower-limb critical ischemia: An open-label, nonrandomized study in two cohorts.
    Veroux P; Veroux M; Macarone M; Bonanno MG; Tumminelli MG
    Curr Ther Res Clin Exp; 2004 May; 65(3):255-65. PubMed ID: 24672081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombolytic Use in Management of Frostbite Injuries: Eight Year Retrospective Review at a Single Institution.
    Heard J; Shamrock A; Galet C; Pape KO; Laroia S; Wibbenmeyer L
    J Burn Care Res; 2020 May; 41(3):722-726. PubMed ID: 32030427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biopsychosocial factors associated with complications in patients with frostbite.
    Endorf FW; Alapati D; Xiong Y; DiGiandomenico C; Rasimas CS; Rasimas JJ; Nygaard RM
    Medicine (Baltimore); 2022 Aug; 101(34):e30211. PubMed ID: 36042625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe vascular complications in patients affected by systemic sclerosis cyclically treated with iloprost.
    Caramaschi P; Dalla Gassa A; Prati D; Barausse G; Tinazzi I; Ravagnani V; Confente S; Biasi D
    Rheumatol Int; 2012 Jul; 32(7):1933-8. PubMed ID: 21448643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of Intra-arterial Thrombolytic Therapy for Acute Treatment of Frostbite in 62 Patients with Review of Thrombolytic Therapy in Frostbite.
    Gonzaga T; Jenabzadeh K; Anderson CP; Mohr WJ; Endorf FW; Ahrenholz DH
    J Burn Care Res; 2016; 37(4):e323-34. PubMed ID: 25950290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The ILAILL study: iloprost as adjuvant to surgery for acute ischemia of lower limbs: a randomized, placebo-controlled, double-blind study by the italian society for vascular and endovascular surgery.
    de Donato G; Gussoni G; de Donato G; Andreozzi GM; Bonizzoni E; Mazzone A; Odero A; Paroni G; Setacci C; Settembrini P; Veglia F; Martini R; Setacci F; Palombo D
    Ann Surg; 2006 Aug; 244(2):185-93. PubMed ID: 16858180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frostbite treatment: a systematic review with meta-analyses.
    Regli IB; Oberhammer R; Zafren K; Brugger H; Strapazzon G
    Scand J Trauma Resusc Emerg Med; 2023 Dec; 31(1):96. PubMed ID: 38072923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The safety of iloprost in systemic sclerosis in a real-life experience.
    Bellando-Randone S; Bruni C; Lepri G; Fiori G; Bartoli F; Conforti ML; Moggi-Pignone A; Guiducci S; Giuggioli D; Colaci M; Spinella A; Ferri C; Matucci-Cerinic M
    Clin Rheumatol; 2018 May; 37(5):1249-1255. PubMed ID: 29470737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Remote Delivery of Thrombolytics Prior to Transfer to a Regional Burn Center for Tissue Salvage in Frostbite: A Single-center Experience of 199 Patients.
    Carmichael H; Michel S; Smith TM; Duffy PS; Wiktor AJ; Lambert Wagner A
    J Burn Care Res; 2022 Jan; 43(1):54-60. PubMed ID: 33657205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term survival of patients with critical limb ischemia treated with iloprost: response rate and predictive criteria. A retrospective analysis of 102 patients.
    Melillo E; Lucaccini E; Berchiolli R; Adami D; Nuti M; Dell'Omo G; Farina A; Panigada G; Roberts AT; Meini S
    Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5233-5241. PubMed ID: 28051243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Revision Surgery Following Severe Frostbite Injury Compared to Similar Hand and Foot Burns.
    Coward A; Endorf FW; Nygaard RM
    J Burn Care Res; 2022 Sep; 43(5):1015-1018. PubMed ID: 35986492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FDA Approves Iloprost as First Drug to Treat Severe Frostbite.
    Harris E
    JAMA; 2024 Mar; 331(11):907. PubMed ID: 38416474
    [No Abstract]   [Full Text] [Related]  

  • 40. Urban Frostbite: Strategies for Limb Salvage.
    Shenaq DS; Beederman M; O'Connor A; Teele M; Robinson MR; Gottlieb LJ
    J Burn Care Res; 2019 Aug; 40(5):613-619. PubMed ID: 30990527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.